Published: 13 December 2017

Recent Approvals of Medicines Containing a New Active Ingredient

Prescriber Update 38(4):
December 2017

For period 16 July 2017 to 15 October 2017.

Trade Name (active ingredient)* Dose Form and Strength Therapeutic Area
Afluria Quad (influenza vaccine polyvalent) Suspension for injection 60 µg/0.5mL Influenza A & B immunisation
Elelyso (taliglucerase alfa) Powder for injection 200 U Type 1 Gaucher disease
Jaqinus (tofacitinib) Film coated tablet 5 mg Rheumatoid arthritis
Tagrisso (osimertinib) Film coated tablet 40 mg and 80 mg EGFR T790M mutation-positive non-small cell lung cancer

* New active ingredient shown in bold type
Not available

The data sheets for currently marketed prescription medicines are published on the Medsafe website (